牛叉诊股

[{"date":"2025.07.03","stock":"3.83","trade":"2.52","ind":"1.17"},{"date":"2025.07.02","stock":"-2.02","trade":"-1.00","ind":"-0.61"},{"date":"2025.07.01","stock":"5.26","trade":"3.49","ind":"0.11"},{"date":"2025.06.30","stock":"1.23","trade":"0.95","ind":"0.83"},{"date":"2025.06.27","stock":"0.72","trade":"0.71","ind":"0.34"},{"date":"2025.06.26","stock":"-0.72","trade":"-1.17","ind":"-0.48"},{"date":"2025.06.25","stock":"-2.20","trade":"-0.56","ind":"1.72"},{"date":"2025.06.24","stock":"0.60","trade":"1.39","ind":"1.68"},{"date":"2025.06.23","stock":"1.02","trade":"1.63","ind":"0.43"},{"date":"2025.06.20","stock":"4.14","trade":"0.13","ind":"-0.47"},{"date":"2025.06.19","stock":"-5.51","trade":"-2.75","ind":"-1.21"},{"date":"2025.06.18","stock":"-7.76","trade":"-1.39","ind":"0.24"},{"date":"2025.06.17","stock":"-2.96","trade":"-1.56","ind":"-0.12"},{"date":"2025.06.16","stock":"4.50","trade":"0.52","ind":"0.41"},{"date":"2025.06.13","stock":"-4.30","trade":"-2.47","ind":"-1.10"},{"date":"2025.06.12","stock":"9.53","trade":"1.34","ind":"-0.11"},{"date":"2025.06.11","stock":"-1.93","trade":"-0.36","ind":"0.83"},{"date":"2025.06.10","stock":"-0.19","trade":"0.69","ind":"-0.86"},{"date":"2025.06.09","stock":"4.42","trade":"4.14","ind":"0.65"},{"date":"2025.06.06","stock":"-0.99","trade":"0.45","ind":"-0.19"},{"date":"2025.06.05","stock":"-3.08","trade":"-1.66","ind":"0.58"}]

仟源医药,深证成指,化学制药指数

压力支撑

该股压力位为10.30元，支撑位为10.02元。

[{"text":"\u538b\u529b\u4f4d","value":"10.30","date":1751472000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.02","date":1751472000,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.2资金面打败了76%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：07月03日 17:45

机构今日流向(万元)	2900.89	机构5日流向(万元)	2172.12
机构10日流向(万元)	-1030.30	机构20日流向(万元)	-13686.71

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量减少42.56万股，其中基金净增仓2家，主力净减仓6家，暂未发现中长期投资价值。

截止2024-12-31，共24家主力机构（一般法人2家，基金22家），持仓量总计661.37万股，占流通A股2.94%
其中，基金持仓与2024-06-30相比：
增仓：3家，增持 20.26万股
减仓：1家，减持 16.90万股
新出现在主力名单中：16家，持有48.45万股
从主力名单中消失：22家，原持有94.37万股

消息面诊股

诊断结果：5.5消息面打败了28%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	取消监事会	2025-06-11
一般消息	股东大会	临时股东大会	2025-05-27
一般消息	分红转增	不分配不转增	2025-04-15
一般消息	募资投向		2025-04-14
重大利好	业绩预告	业绩大幅上升	2025-01-24
一般消息	募资投向	公司购买资产	2025-01-24
一般消息	分红转增	不分配不转增	2024-08-29

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	1条	0条
利空	0条	0条	0条

行业面诊股

诊断结果：7.5行业面打败了94%的股票化学制药行业最新资金流向

近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，跑赢大盘。

[{"date":"2025.07.03","price":"1.17","value":"2.52"},{"date":"2025.07.02","price":"-0.61","value":"-1.00"},{"date":"2025.07.01","price":"0.11","value":"3.49"},{"date":"2025.06.30","price":"0.83","value":"0.95"},{"date":"2025.06.27","price":"0.34","value":"0.71"},{"date":"2025.06.26","price":"-0.48","value":"-1.17"},{"date":"2025.06.25","price":"1.72","value":"-0.56"},{"date":"2025.06.24","price":"1.68","value":"1.39"},{"date":"2025.06.23","price":"0.43","value":"1.63"},{"date":"2025.06.20","price":"-0.47","value":"0.13"},{"date":"2025.06.19","price":"-1.21","value":"-2.75"},{"date":"2025.06.18","price":"0.24","value":"-1.39"},{"date":"2025.06.17","price":"-0.12","value":"-1.56"},{"date":"2025.06.16","price":"0.41","value":"0.52"},{"date":"2025.06.13","price":"-1.10","value":"-2.47"},{"date":"2025.06.12","price":"-0.11","value":"1.34"},{"date":"2025.06.11","price":"0.83","value":"-0.36"},{"date":"2025.06.10","price":"-0.86","value":"0.69"},{"date":"2025.06.09","price":"0.65","value":"4.14"},{"date":"2025.06.06","price":"-0.19","value":"0.45"},{"date":"2025.06.05","price":"0.58","value":"-1.66"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	昂利康	151.79%	45.47%	4.8分
2	美诺华	67.65%	24.88%	5.9分
3	悦康药业	57.70%	24.54%	5.8分
4	永安药业	48.40%	-1.12%	4.6分
5	舒泰神	46.36%	29.17%	5.8分
6	海辰药业	42.32%	3.60%	5.5分
7	微芯生物	31.99%	28.20%	6.0分
8	易明医药	30.40%	-7.46%	3.8分
9	上海谊众	29.78%	17.79%	5.5分
10	广生堂	29.71%	27.93%	5.2分
11	诚意药业	26.93%	28.64%	5.8分
12	翰宇药业	25.03%	11.67%	6.3分
13	北陆药业	23.96%	11.07%	5.4分
14	常山药业	21.96%	-0.07%	4.5分
15	山河药辅	21.12%	26.25%	5.1分
16	泰恩康	19.84%	8.47%	4.7分
17	华海药业	19.26%	18.24%	6.0分
18	前沿生物	17.66%	21.27%	5.1分
19	圣诺生物	14.81%	-1.03%	5.3分
20	博瑞医药	14.23%	6.35%	4.4分
21	千红制药	14.11%	9.32%	5.7分
22	宏源药业	13.62%	5.57%	5.2分
23	ST天圣	13.49%	5.63%	4.0分
24	灵康药业	12.77%	12.55%	5.0分
25	华特达因	11.72%	7.32%	5.7分
26	辰欣药业	11.65%	14.15%	5.6分
27	汇宇制药	10.89%	9.44%	5.8分
28	联环药业	10.33%	5.91%	5.2分
29	*ST三圣	10.31%	1.23%	3.9分
30	北大医药	9.93%	7.58%	5.5分
31	一品红	9.87%	15.09%	5.1分
32	迪哲医药	9.85%	8.05%	5.7分
33	ST景峰	9.72%	-3.29%	4.4分
34	益方生物	9.71%	-2.68%	4.8分
35	丰原药业	9.48%	10.38%	5.1分
36	能特科技	9.39%	16.08%	5.8分
37	民生健康	9.05%	11.27%	5.6分
38	威尔药业	8.79%	16.58%	5.9分
39	通化金马	8.41%	-2.51%	4.9分
40	莱美药业	7.67%	6.22%	4.9分
41	亿帆医药	7.38%	8.87%	5.6分
42	共同药业	7.00%	4.10%	5.0分
43	福元医药	6.85%	4.12%	5.3分
44	南新制药	6.76%	12.01%	5.2分
45	华北制药	6.59%	5.20%	5.6分
46	纳微科技	6.35%	8.24%	6.0分
47	中关村	6.33%	5.93%	5.9分
48	诺泰生物	6.30%	-0.35%	5.4分
49	誉衡药业	6.09%	5.34%	5.6分
50	康芝药业	5.48%	4.69%	4.9分
51	广济药业	5.42%	5.42%	4.8分
52	双鹭药业	5.42%	5.12%	4.8分
53	富士莱	5.38%	10.57%	5.3分
54	津药药业	5.31%	5.83%	5.6分
55	盟科药业	5.27%	10.41%	5.4分
56	海正药业	5.22%	5.33%	5.8分
57	仟源医药	5.17%	9.18%	5.7分
58	小方制药	5.15%	7.39%	5.8分
59	本立科技	5.10%	8.37%	5.2分
60	华仁药业	4.95%	5.61%	5.4分
61	尔康制药	4.95%	9.00%	5.5分
62	振东制药	4.92%	6.83%	5.1分
63	海创药业	4.90%	6.61%	4.6分
64	亚虹医药	4.86%	6.98%	5.6分
65	罗欣药业	4.70%	6.75%	4.9分
66	天新药业	4.39%	5.69%	5.5分
67	卫信康	4.06%	14.27%	5.8分
68	西点药业	4.05%	7.04%	4.8分
69	福安药业	3.78%	4.52%	5.3分
70	赛分科技	3.78%	4.76%	5.1分
71	奥锐特	3.75%	4.35%	5.6分
72	拓新药业	3.34%	8.36%	4.3分
73	亨迪药业	3.28%	5.49%	4.7分
74	东亚药业	3.24%	3.52%	4.9分
75	多瑞医药	3.19%	4.73%	4.5分
76	国邦医药	3.16%	3.16%	5.8分
77	海森药业	3.06%	8.89%	4.6分
78	莎普爱思	3.05%	5.71%	5.1分
79	苑东生物	2.88%	8.27%	5.4分
80	吉贝尔	2.65%	1.36%	4.5分
81	宣泰医药	2.63%	4.66%	4.9分
82	天宇股份	2.22%	13.52%	5.6分
83	华邦健康	2.16%	2.65%	4.9分
84	花园生物	2.10%	7.24%	4.5分
85	信立泰	2.06%	3.35%	4.7分
86	海欣股份	2.05%	6.40%	4.9分
87	普洛药业	1.98%	3.15%	5.5分
88	复旦张江	1.82%	4.56%	5.4分
89	神奇制药	1.80%	7.11%	5.4分
90	丽珠集团	1.68%	2.14%	5.1分
91	新华制药	1.65%	3.77%	5.3分
92	新和成	1.61%	4.10%	5.7分
93	金陵药业	1.60%	2.65%	4.9分
94	东北制药	1.33%	3.50%	5.3分
95	哈药股份	1.32%	5.49%	6.0分
96	泽璟制药	1.32%	2.07%	5.5分
97	德展健康	1.20%	5.30%	4.7分
98	复星医药	1.15%	3.20%	5.5分
99	京新药业	1.12%	5.19%	5.5分
100	九典制药	1.05%	6.38%	5.1分
101	健友股份	0.99%	4.00%	4.8分
102	浙江医药	0.93%	5.93%	5.9分
103	金城医药	0.89%	10.13%	5.6分
104	国药现代	0.74%	1.69%	5.2分
105	力生制药	0.72%	3.22%	4.9分
106	奥翔药业	0.66%	6.49%	5.7分
107	亚太药业	0.25%	4.76%	5.0分
108	海思科	0.25%	4.11%	5.1分
109	艾力斯	0.15%	1.69%	5.3分
110	向日葵	0.00%	6.79%	5.0分
111	-	0.00%	-0.29%	分
112	仙琚制药	-0.11%	2.18%	4.9分
113	富祥药业	-0.11%	6.54%	4.4分
114	东诚药业	-0.20%	2.09%	4.8分
115	科伦药业	-0.24%	6.23%	5.3分
116	同和药业	-0.25%	7.61%	4.7分
117	金石亚药	-0.30%	8.15%	4.8分
118	*ST苏吴	-0.40%	8.62%	5.3分
119	哈三联	-0.45%	16.67%	4.3分
120	百利天恒	-0.61%	0.16%	4.4分
121	新诺威	-0.80%	-1.90%	4.2分
122	海翔药业	-0.85%	7.13%	4.7分
123	汉商集团	-0.90%	5.38%	5.4分
124	百济神州	-1.13%	-8.57%	4.6分
125	润都股份	-1.24%	4.15%	4.3分
126	-	-1.32%	0.27%	分
127	人福医药	-1.73%	4.30%	5.6分
128	海普瑞	-2.05%	3.64%	4.7分
129	复旦复华	-2.50%	0.14%	4.5分
130	恒瑞医药	-2.62%	0.75%	5.9分
131	华纳药厂	-2.82%	14.50%	5.9分
132	立方制药	-3.13%	4.14%	5.2分
133	键凯科技	-3.23%	6.29%	5.2分
134	健康元	-3.30%	2.29%	5.0分
135	司太立	-3.44%	7.09%	5.9分
136	赛托生物	-3.57%	1.11%	4.4分
137	川宁生物	-3.57%	1.93%	4.6分
138	奥赛康	-3.98%	3.99%	5.0分
139	华润双鹤	-4.33%	1.08%	5.0分
140	首药控股	-4.34%	8.15%	4.6分
141	科源制药	-4.80%	5.11%	4.3分
142	贝达药业	-4.87%	3.70%	5.1分
143	兴齐眼药	-5.52%	2.15%	4.9分
144	溢多利	-5.79%	2.46%	4.4分
145	海南海药	-6.32%	5.37%	4.8分
146	*ST赛隆	-6.56%	2.67%	3.4分
147	鲁抗医药	-6.62%	2.21%	5.0分
148	恩华药业	-7.03%	0.67%	4.9分
149	新天地	-7.10%	6.50%	4.5分
150	华东医药	-7.56%	0.52%	5.1分
151	河化股份	-14.29%	7.81%	5.5分
152	-	-23.69%	0.00%	分
153	-	-	-38.25%	分

<上一页 1 2 3 4 5...26 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.9基本面打败了85%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（30分）

基本面得分最高的股票

[ 截止日期：2025-03-31 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 30/227 ， 31/227。

[{"date":"2025-03-31","value":"3.45","vol":"-0.17"},{"date":"2024-12-31","value":"8.95","vol":"19.44"},{"date":"2024-09-30","value":"7.07","vol":"4.58"},{"date":"2024-06-30","value":"5.43","vol":"3.53"},{"date":"2024-03-31","value":"3.00","vol":"2.30"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净资产收益率(%)	3.45	8.95	7.07	5.43	3.00
行业(%)	-0.17	19.44	4.58	3.53	2.30

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"69.51","vol":"49.23"},{"date":"2024-12-31","value":"66.91","vol":"51.10"},{"date":"2024-09-30","value":"66.99","vol":"50.51"},{"date":"2024-06-30","value":"66.67","vol":"50.84"},{"date":"2024-03-31","value":"65.96","vol":"50.75"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
销售毛利率(%)	69.51	66.91	66.99	66.67	65.96
行业(%)	49.23	51.10	50.51	50.84	50.75

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 84/227 ， 109/227。

[{"date":"2025-03-31","value":"-4.09","vol":"-0.86"},{"date":"2024-12-31","value":"5.92","vol":"17.58"},{"date":"2024-09-30","value":"6.45","vol":"45.26"},{"date":"2024-06-30","value":"9.72","vol":"705.46"},{"date":"2024-03-31","value":"3.44","vol":"744.46"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
营业收入同比增长率(%)	-4.09	5.92	6.45	9.72	3.44
行业(%)	-0.86	17.58	45.26	705.46	744.46

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"-43.17","vol":"-21.71"},{"date":"2024-12-31","value":"67.45","vol":"-40.60"},{"date":"2024-09-30","value":"422.48","vol":"-0.63"},{"date":"2024-06-30","value":"238.89","vol":"8.83"},{"date":"2024-03-31","value":"947.75","vol":"18.72"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净利润同比增长率(%)	-43.17	67.45	422.48	238.89	947.75
行业(%)	-21.71	-40.60	-0.63	8.83	18.72

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 50/227 ， 102/227。

[{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.57","vol":"0.43"},{"date":"2024-09-30","value":"0.41","vol":"0.33"},{"date":"2024-06-30","value":"0.27","vol":"0.23"},{"date":"2024-03-31","value":"0.13","vol":"0.12"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
总资产周转率(次)	0.12	0.57	0.41	0.27	0.13
行业(次)	0.10	0.43	0.33	0.23	0.12

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.40","vol":"0.67"},{"date":"2024-12-31","value":"2.21","vol":"3.23"},{"date":"2024-09-30","value":"1.69","vol":"2.17"},{"date":"2024-06-30","value":"1.03","vol":"1.51"},{"date":"2024-03-31","value":"0.52","vol":"0.74"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
存货增长率(次)	0.40	2.21	1.69	1.03	0.52
行业(次)	0.67	3.23	2.17	1.51	0.74

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-03-31","value":"2.84","vol":"-28.86"},{"date":"2024-12-31","value":"3.31","vol":"-368.97"},{"date":"2024-09-30","value":"1.25","vol":"-9.88"},{"date":"2024-06-30","value":"11.81","vol":"-252.28"},{"date":"2024-03-31","value":"18.73","vol":"-3.76"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
现金流量净额/营业收入	2.84	3.31	1.25	11.81	18.73
行业	-28.86	-368.97	-9.88	-252.28	-3.76

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.87","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.70","vol":"2.19"},{"date":"2024-03-31","value":"","vol":"0.00"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资本支出／折旧和摊销	-	0.87	-	1.70	-
行业	0.00	2.00	0.00	2.19	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 83/227 ， 49/227。

[{"date":"2025-03-31","value":"0.96","vol":"3.59"},{"date":"2024-12-31","value":"0.88","vol":"3.32"},{"date":"2024-09-30","value":"0.84","vol":"3.67"},{"date":"2024-06-30","value":"0.99","vol":"3.60"},{"date":"2024-03-31","value":"0.93","vol":"3.71"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
流动比率	0.96	0.88	0.84	0.99	0.93
行业	3.59	3.32	3.67	3.60	3.71

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.59","vol":"2.81"},{"date":"2024-12-31","value":"0.60","vol":"2.62"},{"date":"2024-09-30","value":"0.58","vol":"2.92"},{"date":"2024-06-30","value":"0.62","vol":"2.89"},{"date":"2024-03-31","value":"0.57","vol":"3.06"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
速动比率	0.59	0.60	0.58	0.62	0.57
行业	2.81	2.62	2.92	2.89	3.06

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 56/227 ， 4/227。

[{"date":"2025-03-31","value":"64.67","vol":"33.96"},{"date":"2024-12-31","value":"61.35","vol":"34.28"},{"date":"2024-09-30","value":"44.18","vol":"32.89"},{"date":"2024-06-30","value":"45.03","vol":"33.06"},{"date":"2024-03-31","value":"45.58","vol":"32.53"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资产负债率(%)	64.67	61.35	44.18	45.03	45.58
行业(%)	33.96	34.28	32.89	33.06	32.53

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"3.69","vol":"1.46"},{"date":"2024-12-31","value":"2.77","vol":"0.84"},{"date":"2024-09-30","value":"1.04","vol":"0.72"},{"date":"2024-06-30","value":"1.07","vol":"0.70"},{"date":"2024-03-31","value":"1.09","vol":"0.69"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
产权比率 (%)	3.69	2.77	1.04	1.07	1.09
行业(%)	1.46	0.84	0.72	0.70	0.69

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
申万宏源	2025-04-28	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"-0.91","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-1.19","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.91","blueLineValue":"0.36","type":"YC"}]

[仟源医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]